Humanized CD7 CAR T-cell Therapy for R/R CD7+ T Cell Lymphoma
Latest Information Update: 05 Oct 2021
At a glance
- Drugs Anti-CD7 chimeric antigen receptor T-cell therapy-PersonGen Biomedicine (Primary)
- Indications Non-Hodgkin's lymphoma; T-cell lymphoma
- Focus Adverse reactions; Therapeutic Use
- 05 Oct 2021 New trial record